Delivery Order SPE2DB20D1100-SPE2DB25FE2N3
Award Date 8/25/25
Potential Completion Date 8/26/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,015.96 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 ml pen (semaglutide injection) on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $69,595.58 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by August 6, 2025. Performance will be executed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under a child contract vehicle,...
- The Defense Logistics Agency awarded a $12,953.73 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This contract utilizes firm fixed price pricing with a completion date of June 20, 2025, and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $10,186.58 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections. This firm fixed price, non-set-aside delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $16,297.57 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 ml pen injections, with a ceiling value of $1,143.87 and an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,848.75 to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 21, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's larger pharmaceutical supply framework with the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used in diabetes and weight management treatment. This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to...
- The Defense Logistics Agency awarded a $25,353.06 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 10 mg/0.5 mL pens on September 10, 2025, with an ultimate completion date of September 11, 2025. This is a non-set-aside competitive award executed as a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,525.20 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 19, 2025. The work is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small transaction within the...